NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

HEALthy Brain and Child Development Study - COVID-19 Supplement

CompletedN/A

Sponsor: Boston Children's Hospital

Conditions: Child Development, Prenatal Infection, Prenatal Stress, Covid19

Interventions: No Intervention

Countries: United States

The purpose of this study is to advance the scientific understanding of how a prenatal COVID-19 infection and associated psychological distress influences infant neurodevelopment. This project will aim to shed light on how families and child development are impacted by the current COVID-19 pandemic and will work to better support these families and children as they grow.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* English or Spanish- speaking of any ethnicity
* Women, aged 18 or older
* Women who received COVID-19 diagnoses during pregnancy OR Women without any SARS-CoV-2 positive test during pregnancy, any suspected COVID illness (even if not tested) or who received a negative COVID-19 test result during pregnancy

Exclusion Criteria:

Participants will be excluded if the child:

* is born at less than 34 weeks or if birth weight is not appropriate for dates
* has an identified genetic, metabolic, syndromic or progressive neurological disorder (e.g., Down Syndrome, Rett Syndrome, Tuberous Sclerosis, Neurofibromatosis, Fragile X Syndrome) at birth or within the first year

Locations (4)

Boston, Massachusetts, United States
Boston, Massachusetts, United States
Boston, Massachusetts, United States
Boston, Massachusetts, United States